Budget Amount *help |
¥17,160,000 (Direct Cost: ¥13,200,000、Indirect Cost: ¥3,960,000)
Fiscal Year 2011: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2010: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2009: ¥8,580,000 (Direct Cost: ¥6,600,000、Indirect Cost: ¥1,980,000)
|
Research Abstract |
In this study, we designed DOTA-MN2 and DOTA-TZ2, employing metronidazole moiety as a recognition site of hypoxic tumors and Ac-TZ14011 peptide as a CXCR4 ligand, respectively. Radiogallium-DOTA-MN2 exhibited the high stability and significant accumulation in the hypoxic tumors. Ga-DOTA-TZ2 showed the high affinity to CXCR4 in vitro. These results provide useful information about the chemical design of radiogallium-labeled radiopharmaceuticals for PET studies.
|